Twist Bioscience Q4 EPS $(0.32) Beats $(0.34) Estimate, Sales $126.644M Beat $123.085M Estimate

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 28.89 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $126.644 million which beat the analyst consensus estimate of $123.085 million by 2.89 percent. This is a 27.91 percent increase over sales of $99.009 million the same period last year.